NSIM
BNGO icon

North Star Investment Management’s Bionano Genomics BNGO Stock Holding History

North Star Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– – – 1307
2022
Q4 		– Hold
0
– – – 1310
2022
Q3 		– Hold
0
– – – 1135
2022
Q2 		– Hold
0
– – – 1136
2022
Q1 		– Hold
0
– – – 1148
2021
Q4 		– Sell
-3
Closed -$8.02K – 1178
2021
Q3 		$11K Buy
+3
New +$10.5K ﹤0.01% 840
2021
Q2 		– Hold
0
– – – 1096
2021
Q1 		– Sell
-8
Closed -$15K – 1057
2020
Q4 		$15K Buy
+8
New +$2.99K ﹤0.01% 715

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

North Star Investment Management's BNGO Position: Q1 2023 in Review

North Star Investment Management held its Bionano Genomics (BNGO) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

North Star Investment Management first reported a position in BNGO in Q4 2020 and has held it in 2 quarters since. The position peaked at $15K in Q4 2020. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • North Star Investment Management held 0 shares of Bionano Genomics worth $0 as of Q1 2023.
  • North Star Investment Management left its Bionano Genomics share count unchanged in Q1 2023.
  • Bionano Genomics made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2023, its #1307 holding.
  • North Star Investment Management first reported a position in Bionano Genomics in Q4 2020 and has held it in 2 quarters since.
  • North Star Investment Management's Bionano Genomics position peaked at $15K in Q4 2020.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on North Star Investment Management's 13F filing for Q1 2023, filed 27 Apr 2023.